July 8, 2024 – Page 8 – Goldea Capital

Calibre Receives Environmental Approval for Development and Operation of the Volcan Gold Deposit located in the Libertad Mine Complex

Written by Customer Service on July 8, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, July 08, 2024 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the “Company” or “Calibre”) is pleased to announce that the corresponding Nicaraguan authorities have granted the Company the key environmental permits for the development and production of the open pit mines at the Volcan gold deposit (“Volcan”) located approximately 5 km south of the Libertad mill. Darren Hall, President and Chief Executive Officer of Calibre, stated: “Approval of the Volcan permit demonstrates the value of our hub and spoke operating strategy as we achieve another significant milestone in Calibre’s efforts to organically grow gold production. With an initial open pit resource averaging 2.0 g/t gold, 2023 drilling confirms that the deposit can host higher-grade, near-surface gold mineralization. With receipt...

Brunswick Corporation Schedules 2024 Second Quarter Earnings Conference Call

Written by Customer Service on July 8, 2024. Posted in Earnings Releases And Operating Results.

METTAWA, Ill., July 08, 2024 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) will release its second quarter financial results on Thursday, July 25, 2024 before the market opens by way of an advisory release, notifying the public that the complete and full-text results will be available on the Company’s website at https://ir.brunswick.com. The results will also be available on the SEC’s website with the Form 8-K filing of the release at http://goo.gl/wJQN1. The Company will hold a conference call at 10 a.m. CDT/ 11 a.m. EDT, Thursday, July 25, 2024, hosted by David M. Foulkes, chief executive officer, Ryan M. Gwillim, executive vice president and chief financial officer and Neha Clark, senior vice president, enterprise finance. A copy of the presentation to be used on this call will be available when the results are released...

Man Group PLC : Form 8.3 – Keywords Studios plc

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Man Group PLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Keywords Studios plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position...

Himax Technologies, Inc. Schedules Second Quarter 2024 Financial Results Conference Call on Thursday, August 8 at 8:00 AM EDT

Written by Customer Service on July 8, 2024. Posted in Public Companies.

TAINAN, Taiwan, July 08, 2024 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that it will hold a conference call with investors and analysts on Thursday, August 8 at 8:00 a.m. US Eastern Daylight Time and 8:00 p.m. Taiwan Time to discuss the Company’s second quarter 2024 financial results. HIMAX TECHNOLOGIES SECOND QUARTER 2024 EARNINGS CONFERENCE CALL DATE: Thursday, August 8, 2024 TIME: U.S. 8:00 a.m. EDT Taiwan 8:00 p.m. Live Webcast (Video and Audio): http://www.zucast.com/webcast/HlPPY5TZ Toll Free Dial-in Number (Audio Only): Hong Kong 2112-1444 Taiwan 0080-119-6666 Australia 1-800-015-763 Canada 1-877-252-8508 China (1) 4008-423-888 China...

Danske Bank share buy-back programme: Transactions in week 27

Written by Customer Service on July 8, 2024. Posted in Public Companies.

Company announcement no. 29 2024 Group CommunicationsBernstorffsgade 40DK-1577 København VTel. +45 45 14 00 00 8 July 2024 Danske Bank share buy-back programme: Transactions in week 27 On 2 February 2024, Danske Bank A/S announced a share buy-back programme for a total of DKK 5.5 billion, with a maximum of 70 million shares, in the period from 5 February 2024 to 31 January 2025, at the latest, as described in company announcement no. 2 2024. The programme is being carried out under Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbour Rules. The following transactions were made under the share buy-back programme in week 27: Number of shares VWAP DKK Gross valueDKK Accumulated,...

Sydbank share buyback programme: transactions in week 27

Written by Customer Service on July 8, 2024. Posted in Public Companies.

Company Announcement No 29/2024 Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk 8 July 2024 Dear Sirs Sydbank share buyback programme: transactions in week 27On 28 February 2024 Sydbank announced a share buyback programme of DKK 1,200m. The share buyback programme commenced on 4 March 2024 and will be completed by 31 January 2025. The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under the share buyback...

Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery

Written by Customer Service on July 8, 2024. Posted in Mergers And Acquisitions.

PRESS RELEASE Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery Synsight provides Iktos with an exclusive worldwide license to INSERM’s patented technology enabling high performance AI-driven in cellulo screening of modulators of protein-protein and RNA-protein interactions The merger further complements Iktos’ AI-based drug discovery platform, that currently includes generative AI design, Retrosynthesis, and AI-driven automated synthesis capabilities by adding the key step of automated biological testing Paris, July 8th 2024 – Iktos, a company specializing in Artificial Intelligence (AI) and Robotics for new drug design, announces the acquisition of Synsight, a French biotech company applying AI and high-content cell imaging to the...

LEXIBOOK: 2023-24 ANNUAL RESULTS IN LINE WITH EXPECTATIONS: ANNUAL SALES AT €58.6M (+14.4%). EBIT AND NET RESULT UP RESPECTIVELY TO +6.0M€ AND +5.0M€ THANKS TO AN EXCEPTIONAL CONJUNCTION OF POSITIVE FACTORS.

Written by Customer Service on July 8, 2024. Posted in Earnings Releases And Operating Results.

Courtabœuf, July 08, 2024 at 7:00 a.m. LEXIBOOK: 2023-24 ANNUAL RESULTS IN LINE WITH EXPECTATIONS: ANNUAL SALES AT €58.6M (+14.4%). EBIT AND NET RESULT UP RESPECTIVELY TO +6.0M€ AND +5.0M€ THANKS TO AN EXCEPTIONAL CONJUNCTION OF POSITIVE FACTORS. ENCOURAGING OUTLOOK FOR FY 2024-25 DESPITE UNCERTAINTIES ON THE IMPACT OF FREIGHT COSTS AND EXCHANGE PERIODS AND ON CONSUMPTION. Annual sales: a historic fiscal year after 4 years of growth. Over the full fiscal year, which grew by 13.3% in 22-23, sales rose by a further 14.4% to €58.6m, compared with €51.2m a year earlier. Against a backdrop of a 3.6% appreciation of the euro against the US dollar in 1 year, and a very significant reduction in freight costs, Group margins logically improved as Lexibook succeeded in maintaining its prices, or even...

VIRBAC: exceptional first-half growth and guidance raised for 2024

Written by Customer Service on July 8, 2024. Posted in Public Companies.

Compte tenu de la dynamique très positive de nos ventes observée sur le premier semestre (croissance du chiffre d’affaires attendue autour de 16% à taux de change constants1 et ~11% à taux de change et périmètre constants) qui devrait se poursuivre sur le second semestre, ainsi que d’un marché de la santé animale particulièrement porteur, la croissance du chiffre d’affaires 2024 à taux de change constants est attendue entre 12,5% et 14,5%1 (correspondant à une croissance désormais attendue de 7% à 9% à taux de change et périmètre constants). Le ratio de “résultat opérationnel courant avant amortissement des actifs issus d’acquisitions” sur “chiffre d’affaires” devrait se consolider autour de 16% à taux de change et périmètre constants. A périmètre réel, l’impact des acquisitions Sasaeah et Globion devrait être légèrement accrétif sur ce...

VIRBAC announces executive management changes

Written by Customer Service on July 8, 2024. Posted in Public Companies.

Sébastien Huron leaves the company, Habib Ramdani takes over while the Group recruits its next chief executive officer Virbac announces the resignation of Sébastien Huron from his position as chief executive officer. He will leave the Virbac Group’s executive management by September 30, 2024, to take a break from his professional life. The board of directors has decided to appoint Habib Ramdani, currently chief financial officer and deputy chief executive officer, as interim CEO, to replace Sébastien Huron, while the appointments and compensation committee recruits the next chief executive officer. Backed by the board of directors, Habib will be able to count on the full support of the Group executive committee in executing the roadmap of our Virbac 2030 project. The board of directors warmly thanks Sébastien for the tremendous...

Day: July 8, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice